Molecular and Clinical Aspects of Inherited Cardiomyopathies

References

• Ott J. Analysis of Human Genetic Linkage. The Johns Hopkins University Press, Baltimore, MD 1991
   Google Scholar
• Hejtmancik J F, Roberts R. Molecular genetics and application of linkage analysis. Molecular Basis of Cardiology, R Roberts. Blackwell Scientific Publications, Cambridge 1993; 355–81
   Google Scholar
• Weissenbach J, Gyapay G, Dib C, et al. A second generation linkage map of the human genome. Nature 1992; 359: 794–801
   PubMed Web of Science ®Google Scholar
• Jarcho J A, McKenna W, Pare J AP, et al. Mapping a gene for familial hypertrophic cardiomyopathy to chromosome 14q1. N Engl J Med 1989; 321: 1372–8
   PubMed Web of Science ®Google Scholar
• Carrier L, Hengstenberg C, Beckmann J S, et al. Mapping of a novel gene for familial hypertrophic cardiomyopathy to chromosome 11. Nat Genet 1993; 4: 311–13
   PubMed Web of Science ®Google Scholar
• Thierfelder L, Watkins H, MacRae C, et al. Alpha-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere. Cell 1994; 77: 701–12
   PubMed Web of Science ®Google Scholar
• Watkins H, MacRae C, Thierfelder L, et al. A disease locus for familial hypertrophic cardiomyopathy maps to chromosome 1q3. Nat Genet 1993; 3: 333–7
   PubMed Web of Science ®Google Scholar
• Thierfelder L C, MacRae C, Watkins I I, et al. A familial hypertrophic cardiomyopathy locus maps to chromosome 15q2. Proc Natl Acad Sci USA 1993; 90: 6270–4
   PubMed Web of Science ®Google Scholar
• Marian A J, Roberts R. Molecular genetics of hypertrophic cardiomyopathy. Annu Rev Med 1995; 46: 213–22
   Google Scholar
• Fananapazir L, Epstein N D. Genotype-phenotype correlations in hypertrophic cardiomyopathy: insights provided by comparisons of kindreds with distinct and identical β-myosin heavy chain gene mutations. Circulation 1994; 89: 22–32
   PubMed Web of Science ®Google Scholar
• Anan R, Greve G, Thierfelder L, et al. Prognostic implications of novel β cardiac myosin heavy chain gene mutations that cause familial hypertrophic cardiomyopathy. J Clin Invest 1994; 93: 280–5
   PubMed Web of Science ®Google Scholar
• Towbin J, Roberts R. Cardiovascular diseases due to genetic abnormalities. Hurst's The Heart: Arteries and Veins, R C Schlant, R W Alexander. McGraw Hill, Inc., New York, NY 1994; 1725–59
   Google Scholar
• Roberts W C, Ferrans V J. Morphologic observations in the cardiomyopathies. Hypertrophic Cardiomyopathy: The Therapeutic Role of Calcium Antagonists, M Kaltenbach, S E Epstein. Springer-Verlag, New York, NY 1982; 59–83
   Google Scholar
• Hejtmancik J F, Brink P A, Towbin J, et al. Localization of the gene for familial hypertrophic cardiomyopathy to chromosome 14q1 in a diverse U.S. population. Circulation 1991; 83: 1592–17
   Google Scholar
• Liew C C, Sole M J, Yamauchi-Takihara K, et al. Complete sequence and organization of the human cardiac β-myosin heavy chain gene. Nucleic Acids Res 1990; 18: 3647–51
   PubMedGoogle Scholar
• Warrick H M, Spudich J A. Myosin structure and function in cell motility. Annu Rev Cell Biol 1987; 3: P379–421
   PubMedGoogle Scholar
• Finer J T, Simmons R M, Spudich J A. Single myosin mechanics: picoNewton forces and nanometer steps. Nature 1994; 368: 113–19
   PubMed Web of Science ®Google Scholar
• Swynghedauw B. Developmental and functional adaptation of contractile proteins in cardiac and skeletal muscles. Physiol Rev 1986; 3: 710–60
   Google Scholar
• Roberts R, Marian A J, Bachinski L L. Overview: application of molecular biology to medical genetics. Inborn Heart Disease—Developmental Mechanisms, R R Markwald, E B Clark, A Takao. Futura Press, Mount Kisco, NY 1994; 87–111
   Google Scholar
• Perryman M B, Yu Q T, Marian A J, et al. Expression of a missense mutation in the mRNA for β-myosin heavy chain in myocardial tissue in hypertrophic cardiomyopathy. J Clin Invest 1992; 90: 271–7
   Google Scholar
• Greve G, Bachinski L L, Friedman D L, et al. Isolation of a de novo mutant myocardial βMHC protein in a pedigree with hypertrophic cardiomyopathy. Hum Mol Genet 1994; 3: 2073–5
   Google Scholar
• Cuda G, Fananapazir L, Epstein N D, Sellers J. Abnormal myosin in-vitro motility activity in two hypertrophic cardiomyopathy kindreds with distinct cardiac beta myosin heavy chain gene mutations. Circulation 1992; 86: 1–229
   Google Scholar
• Cuda G, Sellers J, Epstein N D, Fananapazir L. In-vitro motility activity of β-cardiac myosin depends on the nature of the β-myosin heavy chain gene mutations in hypertrophic cardiomyopathy. Circulation 1993; 88: I–343, (Abstract)
   Google Scholar
• Watkins H, Rosenzweig A, Hwang D, et al. Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy. N Engl J Med 1992; 326: 1108–14
   PubMed Web of Science ®Google Scholar
• Marian A J, Mares A, Jr, Kelly D P, et al. Sudden cardiac death in hypertrophic cardiomyopathy: variability in phenotypic expression of β-myosin heavy chain mutations. Eur Heart J 1995, (in press)
   Google Scholar
• Epstein N D, Cohn G M, Cyran F, Fananapazir L. Differences in clinical expression of hypertrophic cardiomyopathy associated with two distinct mutations in the β-myosin heavy chain gene: a 908 Leu-Val mutation and a 403 Arg-Gin mutation. Circulation 1992; 86: 345–52
   PubMedGoogle Scholar
• Vybiral T, Roberts R, Deltiker P R, Epstein H F. Accumulation and assembly of myosin in the Arg-Gin β-MHC hypertrophic cardiomyopathy mutant. Circ Res 1992; 71: 1404–9
   Google Scholar
• Cuda G, Fananapazir L, Zhu W, Sellers J R, Epstein N D. Skeletal muscle expression and abnormal function of β myosin in hypertrophic cardiomyopathy. J Clin Invest 1993; 91: 2861–5
   PubMed Web of Science ®Google Scholar
• Sweeney H L, Straceski A J, Leinwand L A, Tikunov B A, Faust L. Heterologous expression of a cardiomyopathic myosin that is defective in its actin interaction. J Biol Chem 1994; 269: 1603–5
   Google Scholar
• Marian A J, Yu Q T, Mann D L, Graham F L, Roberts R. Expression of a mutation causing hypertrophic cardiomyopathy in adult feline cardiocytes disrupts sarcomere assembly in adult feline cardiac myocytes. Circ Res 1995, (in press)
   Google Scholar
• Marian A J, Yu Q T, Workman R, Greve G, Roberts R. Angiotensin converting enzyme polymorphism in hypertrophic cardiomyopathy and sudden cardiac death. Lancet 1993; 342: 1085–6
   PubMed Web of Science ®Google Scholar
• Roberts R. Molecular genetics: therapy or terror?. Circulation 1994; 89: 499–502
   Google Scholar
• Schmidt M A, Michels W, Edwards W D, Miller F A. Familial dilated cardiomyopathy. Am J Med Genet 1988; 31: 135–43
   Google Scholar
• Michels W, Moll P P, Miller F A, et al. The frequency of familial dilated cardiomyopathy in a series of patients with idiopathic dilated cardiomyopathy. N Engl J Med 1992; 326: 77–82
   PubMed Web of Science ®Google Scholar
• Fuster V, Gersh B J, Giuliani E R, Tajik A J, Brandenburg R O, Frye R L. The natural history of idiopathic dilated cardiomyopathy. Am J Cardiol 1981; 47: 525–31
   PubMed Web of Science ®Google Scholar
• Vincenzo-Fragola P, Autore C, Picelli A, Sommariva L, Cannata D, Sangiorgi M. Familial idiopathic dilated cardiomyopathy. Am Heart J 1988; 115: 912–14
   Google Scholar
• Manolio T A, Baughman K L, Rodeheffer R, et al. Prevalence and etiology of idiopathic dilated cardiomyopathy (Summary of a National Heart, Lung, and Blood Institute Workshop). Am J Cardiol 1992; 69: 1458–66
   Google Scholar
• Kass S, Mac Rae C, Graber H L, et al. A gene defect that causes conduction system disease and dilated cardiomyopathy maps to chromosome 1p1–1q1. Nat Genet 1994; 7: 546–51
   PubMed Web of Science ®Google Scholar